Attilio Bondanza | Car-T Clinical Program Leader
Novartis Institutes for Biomedical Research

Attilio Bondanza, formerly Head of Innovative Immunotherapies Unit and Professor at San Raffaele University Hospital (Milano, IT) has 20 years of experience in pre-clinical and clinical cell and gene therapy (H index: 31). He has contributed to the EU registration of Zalmoxis (HSV-TK suicide gene-modified T cells in allogeneic hematopoietic stem cell transplantation) and led the clinical program of CD44v6 CAR-T cells in AML and MM of San Raffaele’s until 2017, when he joined Novartis. He is the inventor of 5 international cell and gene therapy patents, 3 of which have been exploited industrially.

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.

Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October